{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:50:02Z","timestamp":1785711002963,"version":"3.56.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Government of India Department of Pharmaceuticals","doi-asserted-by":"publisher","award":["650\/PhD-PE\/19"],"award-info":[{"award-number":["650\/PhD-PE\/19"]}],"id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nano.2026.102934","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:23:02Z","timestamp":1774545782000},"page":"102934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Berberine chloride-loaded polymeric lipid hybrid nanoparticles ameliorate cognitive impairment by reducing phosphorylation of tau at threonine 231"],"prefix":"10.1016","volume":"74","author":[{"given":"Farhan","family":"Mazahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Rahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder K.","family":"Kaundal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awesh K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102934_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nano.2026.102934_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nano.2026.102934_bb0015","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/j.nano.2026.102934_bb0020","article-title":"Prevalence of dementia in India: national and state estimates from a nationwide study","volume":"19","author":"Lee","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.nano.2026.102934_bb0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102934_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144337","article-title":"Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2026.102934_bb0035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/TCRM.S323387","article-title":"Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: a comprehensive literature review","volume":"17","author":"Ruangritchankul","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.nano.2026.102934_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004748","article-title":"Velnacrine for Alzheimer\u2019s disease","author":"Birks","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"2001","key":"10.1016\/j.nano.2026.102934_bb0045","article-title":"Physostigmine for dementia due to Alzheimer\u2019s disease","author":"Coelho Filho","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nano.2026.102934_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7252882","article-title":"Tacrine derivatives in neurological disorders: focus on molecular mechanisms and neurotherapeutic potential","volume":"2022","author":"Mitra","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nano.2026.102934_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40801-023-00362-6","article-title":"Analysis of adverse events of cholinesterase inhibitors and NMDA receptor antagonists on arrhythmias using the Japanese adverse drug event report database","volume":"10","author":"Kobayashi","year":"2023","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.nano.2026.102934_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nano.2026.102934_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s43088-022-00196-1","article-title":"Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials","volume":"11","author":"Tripathi","year":"2022","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"10.1016\/j.nano.2026.102934_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jnutbio.2019.05.009","article-title":"Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer\u2019s disease","volume":"70","author":"Wang","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nano.2026.102934_bb0075","doi-asserted-by":"crossref","DOI":"10.4103\/0972-2327.40220","article-title":"The effect of curcumin (turmeric) on Alzheimer\u2019s disease: an overview","volume":"11","author":"Mishra","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.nano.2026.102934_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/nu14122387","article-title":"Hesperidin: a review on extraction methods, stability and biological activities","volume":"14","author":"Pyrzynska","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.nano.2026.102934_bb0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-170188","article-title":"The mechanisms of action of curcumin in Alzheimer\u2019s disease","volume":"58","author":"Tang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nano.2026.102934_bb0090","article-title":"Hesperidin improves memory function by enhancing neurogenesis in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Lee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.nano.2026.102934_bb0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nano.2026.102934_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.653887","article-title":"Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials","volume":"12","author":"Ye","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.102934_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12101883","article-title":"Neuroprotective properties of berberine: molecular mechanisms and clinical implications","volume":"12","author":"Tian","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.nano.2026.102934_bb0110","article-title":"Effect of berberine on cognitive function and \u03b2-amyloid precursor protein in Alzheimer\u2019s disease models: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.102934_bb0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2174\/1567205015666180702105740","article-title":"Berberine alleviates amyloid-beta pathology in the brain of APP\/PS1 transgenic mice via inhibiting \u03b2\/\u03b3-secretases activity and enhancing \u03b1-secretases","volume":"15","author":"Cai","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nano.2026.102934_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109670","article-title":"Berberine mitigates cognitive decline in an Alzheimer\u2019s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance","volume":"121","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2026.102934_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100070","article-title":"A bird\u2019s eye view on a therapeutically \u2018wonder molecule\u2019: Berberine","volume":"1","author":"Patel","year":"2021","journal-title":"Phytomed Plus"},{"key":"10.1016\/j.nano.2026.102934_bb0130","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nano.2026.102934_bb0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2026.102934_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17425255.2023.2203858","article-title":"Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations","volume":"19","author":"Murakami","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.nano.2026.102934_bb0145","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1021\/acssensors.2c00132","article-title":"Machine learning-assisted SENSOR array based on poly(amidoamine) (PAMAM) dendrimers for diagnosing Alzheimer\u2019s disease","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Sens"},{"key":"10.1016\/j.nano.2026.102934_bb0150","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01652-w","article-title":"Combined therapy for Alzheimer\u2019s disease: tacrine and PAMAM dendrimers co-administration reduces the side effects of the drug without modifying its activity","volume":"21","author":"Igart\u00faa","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2026.102934_bb0155","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/acs.bioconjchem.9b00505","article-title":"Lactoferrin coupled lower generation PAMAM dendrimers for brain targeted delivery of memantine in aluminum-chloride-induced Alzheimer\u2019s disease in mice","volume":"30","author":"Gothwal","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2026.102934_bb0160","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/jacs.2c12214","article-title":"Chiral skeletons of mesoporous silica nanospheres to mitigate Alzheimer\u2019s \u03b2-amyloid aggregation","volume":"145","author":"Xu","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2026.102934_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2021.131065","article-title":"A dual-screening electrochemiluminescent aptasensor based on a mesoporous silica nano-sieve for specific detection of amyloid-\u03b2 monomer","volume":"352","author":"Tan","year":"2022","journal-title":"Sens Actuators B"},{"key":"10.1016\/j.nano.2026.102934_bb0170","article-title":"Transferrin-Pep63-liposomes accelerate the clearance of A\u03b2 and rescue impaired synaptic plasticity in early Alzheimer\u2019s disease models","volume":"7","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nano.2026.102934_bb0175","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1523\/JNEUROSCI.0284-14.2014","article-title":"Multifunctional liposomes reduce brain \u03b2-amyloid burden and ameliorate memory impairment in alzheimer\u2019s disease mouse models","volume":"34","author":"Balducci","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.nano.2026.102934_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuint.2017.02.012","article-title":"Multifunctional liposomes interact with Abeta in human biological fluids: therapeutic implications for Alzheimer\u2019s disease","volume":"108","author":"Conti","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.nano.2026.102934_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2021.02.015","article-title":"Design, development and in-vitro\/in-vivo evaluation of intranasally delivered rivastigmine and N-acetyl cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer\u2019s disease","volume":"163","author":"Kulkarni","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2026.102934_bb0190","article-title":"Smart niosomes of temozolomide for enhancement of brain targeting","volume":"5","author":"De","year":"2018","journal-title":"Nanobiomedicine (Rij)"},{"key":"10.1016\/j.nano.2026.102934_bb0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejps.2018.07.042","article-title":"Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier","volume":"123","author":"M\u00e9sz\u00e1ros","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102934_bb0200","article-title":"Alzheimer\u2019s disease: microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia (Adv. Sci. 4\/2019)","volume":"6","author":"Lu","year":"2019","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2026.102934_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119844","article-title":"Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer\u2019s disease","volume":"238","author":"Yang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2026.102934_bb0210","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1039\/D0TB01101K","article-title":"Non-invasive optical imaging of retinal A\u03b2 plaques using curcumin loaded polymeric micelles in APPswe\/PS1\u0394E9transgenic mice for the diagnosis of Alzheimer\u2019s disease","volume":"8","author":"Chibhabha","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2026.102934_bb0215","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12035-019-01780-w","article-title":"Gold nanoparticles treatment reverses brain damage in Alzheimer\u2019s disease model","volume":"57","author":"dos Santos Tramontin","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nano.2026.102934_bb0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10895-016-1988-8","article-title":"Design and fabrication a gold nanoparticle-DNA based nanobiosensor for detection of microRNA involved in Alzheimer\u2019s disease","volume":"27","author":"Delkhahi","year":"2017","journal-title":"J Fluoresc"},{"key":"10.1016\/j.nano.2026.102934_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340949","article-title":"Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer\u2019s disease by using cytotoxicity assays, TEM and single cell-ICP-MS","volume":"1249","author":"Vicente-Zurdo","year":"2023","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.nano.2026.102934_bb0230","doi-asserted-by":"crossref","first-page":"30261","DOI":"10.1021\/acsami.1c00690","article-title":"Multifunctional selenium quantum dots for the treatment of Alzheimer\u2019s disease by reducing A\u03b2-neurotoxicity and oxidative stress and alleviate neuroinflammation","volume":"13","author":"Guo","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102934_bb0235","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s11011-021-00713-8","article-title":"Administration of selenium nanoparticles reverses streptozotocin-induced neurotoxicity in the male rats","volume":"36","author":"Gholamigeravand","year":"2021","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.nano.2026.102934_bb0240","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-021-02706-x","article-title":"Investigation of therapeutic potential of cerium oxide nanoparticles in Alzheimer\u2019s disease using transgenic Drosophila","volume":"11","author":"Sundararajan","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.nano.2026.102934_bb0245","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.2147\/IJN.S434873","article-title":"Functionalized cerium dioxide nanoparticles with antioxidative neuroprotection for Alzheimer\u2019s disease","volume":"18","author":"Hu","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102934_bb0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.msec.2014.01.005","article-title":"Synthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer\u2019s disease","volume":"37","author":"Zhou","year":"2014","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.nano.2026.102934_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2019.107968","article-title":"Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: novel theranostic agents for Alzheimer\u2019s disease","volume":"173","author":"Cai","year":"2020","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.nano.2026.102934_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuro.2021.05.013","article-title":"PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer\u2019s disease: potential participation of STIMs","volume":"85","author":"Sanati","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nano.2026.102934_bb0265","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nano.2019.02.004","article-title":"Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer\u2019s disease-related pathology in 5XFAD mice","volume":"17","author":"Jeon","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2026.102934_bb0270","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.013","article-title":"Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer\u2019s pathology","volume":"150","author":"Mittal","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102934_bb0275","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1021\/acschemneuro.9b00343","article-title":"Design and biological evaluation of lipoprotein-based donepezil nanocarrier for enhanced brain uptake through oral delivery","volume":"10","author":"Krishna","year":"2019","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.nano.2026.102934_bb0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00222348.2014.984578","article-title":"Synthesis and characterization of acylated polycaprolactone (PCL) nanospheres and investigation of their influence on aggregation of amyloid proteins","volume":"54","author":"Ansari","year":"2015","journal-title":"J Macromol Sci Part B: Phys"},{"key":"10.1016\/j.nano.2026.102934_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.59","article-title":"Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer\u2019s disease","volume":"2","author":"Kulkarni","year":"2010","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102934_bb0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbiotec.2021.03.010","article-title":"Transferrin-functionalized lipid nanoparticles for curcumin brain delivery","volume":"331","author":"Neves","year":"2021","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nano.2026.102934_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111838","article-title":"Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer\u2019s disease: A preclinical evidence","volume":"205","author":"Saini","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2026.102934_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338990","article-title":"Thionine-functionalized three-dimensional carbon nanomaterial-based aptasensor for analysis of A\u03b2 oligomers in serum","volume":"1183","author":"Tao","year":"2021","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.nano.2026.102934_bb0305","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/10717544.2021.1895909","article-title":"Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer\u2019s disease","volume":"28","author":"Wang","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.102934_bb0310","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acssensors.6b00651","article-title":"Graphene oxide-upconversion nanoparticle based optical sensors for targeted detection of mRNA biomarkers present in Alzheimer\u2019s disease and prostate cancer","volume":"2","author":"Vilela","year":"2017","journal-title":"ACS Sens"},{"key":"10.1016\/j.nano.2026.102934_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00564","article-title":"Therapeutic effects of transplanted exosomes containing miR-29b to a rat model of Alzheimer\u2019s disease","volume":"14","author":"Jahangard","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nano.2026.102934_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-019-0150-2","article-title":"RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease","volume":"16","author":"Cui","year":"2019","journal-title":"Immun Ageing"},{"key":"10.1016\/j.nano.2026.102934_bb0325","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-190497","article-title":"Changes in the morphology, number, and pathological protein levels of plasma exosomes may help diagnose Alzheimer\u2019s disease","volume":"73","author":"Sun","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nano.2026.102934_bb0330","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2026.102934_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119553","article-title":"Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer\u2019s disease: a non-invasive approach","volume":"586","author":"Dhas","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102934_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120714","article-title":"Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease","volume":"310","author":"Yang","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2026.102934_bb0345","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.nano.2026.102934_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4687959","article-title":"Nanostructured lipid carriers for improved delivery of therapeutics via the oral route","volume":"2023","author":"Mahor","year":"2023","journal-title":"J Nanotechnol"},{"key":"10.1016\/j.nano.2026.102934_bb0355","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/346581","article-title":"Increasing possibilities of nanosuspension","volume":"2013","author":"Sutradhar","year":"2013","journal-title":"J Nanotechnol"},{"key":"10.1016\/j.nano.2026.102934_bb0360","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","article-title":"Dendrimer toxicity: let\u2019s meet the challenge","volume":"394","author":"Jain","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102934_bb0365","doi-asserted-by":"crossref","first-page":"10044","DOI":"10.1021\/ja048548j","article-title":"Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery","volume":"126","author":"Chen","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2026.102934_bb0370","article-title":"Lipid based vesicular drug delivery systems","volume":"2014","author":"Jain","year":"2014","journal-title":"Adv Pharm"},{"key":"10.1016\/j.nano.2026.102934_bb0375","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1111\/jcmm.13695","article-title":"Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound","volume":"22","author":"Li","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nano.2026.102934_bb0380","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.01.013","article-title":"Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency","volume":"69","author":"Song","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2026.102934_bb0385","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/acs.biomac.3c00832","article-title":"Reversible cross-linked thermoresponsive polycaprolactone micelles for enhanced stability and controlled release","volume":"24","author":"Bhadran","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2026.102934_bb0390","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jat.4037","article-title":"Neurotoxicity of metal-containing nanoparticles and implications in glial cells","volume":"41","author":"Chang","year":"2021","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nano.2026.102934_bb0395","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102934_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081291","article-title":"Polymeric lipid hybrid nanoparticles (Plns) as emerging drug delivery platform\u2014a comprehensive review of their properties, preparation methods, and therapeutic applications","volume":"13","author":"Sivadasan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102934_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2023.100165","article-title":"Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics","volume":"20","author":"Parveen","year":"2023","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.nano.2026.102934_bb0410","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/acsanm.2c05272","article-title":"PEGylated polymer-lipid hybrid nanoparticles to enhance in vivo exposure and uptake of repaglinide in brain cells to treat diabetes-linked neurodegenerative disorders","volume":"6","author":"Wadhwa","year":"2023","journal-title":"ACS Appl Nano Mater"},{"key":"10.1016\/j.nano.2026.102934_bb0415","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/IJN.S210876","article-title":"Recent expansions of novel strategies towards the drug targeting into the brain","volume":"14","author":"Alexander","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102934_bb0420","doi-asserted-by":"crossref","first-page":"18714","DOI":"10.1021\/acsomega.3c00638","article-title":"Hydrocortisone-loaded lipid-polymer hybrid nanoparticles for controlled topical delivery: formulation design optimization and in vitro and in vivo appraisal","volume":"8","author":"Alsaidan","year":"2023","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.nano.2026.102934_bb0425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/0122117385271393231117063750","article-title":"Solid lipid nanoparticles as an innovative lipidic drug delivery system","volume":"13","author":"Waghmare","year":"2025","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.nano.2026.102934_bb0430","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2026.102934_bb0435","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/03639045.2023.2282990","article-title":"Transferrin functionalized poloxamer-chitosan nanoparticles of metformin: physicochemical characterization, in-vitro, and ex-vivo studies","volume":"49","author":"Birajdar","year":"2023","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2026.102934_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21568-8","article-title":"Preparation, physicochemical characterization, and bioactivity evaluation of berberine-entrapped albumin nanoparticles","volume":"12","author":"Younis","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102934_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18525-2","article-title":"Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Hou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102934_bb0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-4347(94)00517-9","article-title":"Determination of berberine in plasma, urine and bile by high-performance liquid chromatography","volume":"665","author":"Chen","year":"1995","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.nano.2026.102934_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.eti.2020.100838","article-title":"Pkweb: an online application for pharmacokinetic data analysis","volume":"19","author":"Dong","year":"2020","journal-title":"Environ Technol Innov"},{"key":"10.1016\/j.nano.2026.102934_bb0460","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2019.06.021","article-title":"Nose-to-brain delivery of hyaluronate \u2013 FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy","volume":"307","author":"Kim","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102934_bb0465","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1039\/C9NR01255A","article-title":"Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT\/GSK-3\u03b2 pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.102934_bb0470","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2013.04.033","article-title":"Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice","volume":"715","author":"Rajasekar","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.nano.2026.102934_bb0475","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0306-4522(97)00695-7","article-title":"Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated tau","volume":"85","author":"Mudher","year":"1998","journal-title":"Neuroscience"},{"issue":"15","key":"10.1016\/j.nano.2026.102934_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70744","article-title":"Berberine ameliorates postoperative cognitive dysfunction in aged mice and regulates the PI3K-AKT pathway: a network pharmacology study","volume":"29","author":"Li","year":"2025","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nano.2026.102934_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00985","article-title":"The neuroprotective action of amidated-kyotorphin on amyloid \u03b2 peptide-induced Alzheimer\u2019s disease pathophysiology","volume":"11","author":"Belo","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.102934_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-43532-9","article-title":"Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer\u2019s disease","volume":"9","author":"Fronza","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102934_bb0495","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","article-title":"Dual-drug loaded nanoparticles of epigallocatechin-3-gallate (EGCG)\/ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer\u2019s disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102934_bb0500","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01980-5","article-title":"Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models","volume":"18","author":"Fassler","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nano.2026.102934_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08674","article-title":"Drug release study of the chitosan-based nanoparticles","volume":"8","author":"Herdiana","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.nano.2026.102934_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080732","article-title":"In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method","volume":"12","author":"Weng","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102934_bb0515","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","article-title":"The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds","volume":"276","author":"Hudson","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.nano.2026.102934_bb0520","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","article-title":"\u03b2-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding","volume":"14","author":"Busciglio","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nano.2026.102934_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061249","article-title":"Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies, nanoparticles and exosomes","volume":"18","author":"Cataldi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102934_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594852","article-title":"Pharmacokinetics and excretion of berberine and its nine metabolites in rats","volume":"11","author":"Feng","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.102934_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci Data"},{"key":"10.1016\/j.nano.2026.102934_bb0540","first-page":"10","article-title":"Object recognition test for studying cognitive impairments in animal models of Alzheimer\u2019s disease","volume":"7S","author":"Bengoetxea","year":"2015","journal-title":"Front Biosci - Scholar"},{"key":"10.1016\/j.nano.2026.102934_bb0545","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn Process"},{"key":"10.1016\/j.nano.2026.102934_bb0550","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.nano.2026.102934_bb0555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchemneu.2018.05.006","article-title":"Okadaic acid\u2013induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons","volume":"92","author":"Metin-Arma\u011fan","year":"2018","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.nano.2026.102934_bb0560","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nano.2026.102934_bb0565","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","article-title":"Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles","volume":"27","author":"Qi","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.102934_bb0570","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.241471","article-title":"Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer\u2019s disease","volume":"13","author":"Xu","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.nano.2026.102934_bb0575","series-title":"Berberine Attenuates Calyculin A-induced Cytotoxicity and Tau Hyperphosphorylation in HEK293 Cells","author":"Yu Guang","year":"2011"},{"key":"10.1016\/j.nano.2026.102934_bb0580","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.241471","article-title":"Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer\u2019s disease","volume":"13","author":"Xu","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.nano.2026.102934_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0300-0","article-title":"A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions","volume":"4","author":"Baker","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nano.2026.102934_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25564","article-title":"Kolaviron neuroprotective effect against okadaic acid-provoked cognitive impairment","volume":"10","author":"Nazari-Serenjeh","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nano.2026.102934_bb0595","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbrc.2016.12.101","article-title":"Passive immunization targeting the N-terminal region of phosphorylated tau (residues 68\u201371) improves spatial memory in okadaic acid induced tauopathy model rats","volume":"483","author":"Subramanian","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2026.102934_bb0600","article-title":"Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles","volume":"21","author":"Zhang","year":"2007","journal-title":"Polym Polym Compos"},{"key":"10.1016\/j.nano.2026.102934_bb0605","doi-asserted-by":"crossref","DOI":"10.1186\/s42649-020-00032-9","article-title":"Hot stage microscopy and its applications in pharmaceutical characterization","volume":"50","author":"Kumar","year":"2020","journal-title":"Appl Microsc"},{"key":"10.1016\/j.nano.2026.102934_bb0610","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8056462","article-title":"Antioxidant compounds in the treatment of Alzheimer\u2019s disease: natural, hybrid, and synthetic products","volume":"2023","author":"Hatami","year":"2023","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.nano.2026.102934_bb0615","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.nano.2026.102934_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000536","article-title":"Mitochondrial oxidative stress causes hyperphosphorylation of tau","volume":"2","author":"Melov","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2026.102934_bb0625","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-85019-6","article-title":"Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials","volume":"11","author":"Jablonsk\u00e1","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102934_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-09270-1","article-title":"Search strategy analysis of Tg4-42 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficits","volume":"12","author":"Curdt","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102934_bb0635","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1021\/acsbiomaterials.4c01260","article-title":"Engineered PLGA core\u2013lipid shell hybrid nanocarriers improve the efficacy and safety of irinotecan to combat colon cancer","author":"Giram","year":"2024","journal-title":"ACS Biomater Sci Eng"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:24:31Z","timestamp":1785709471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":127,"alternative-id":["S1549963426000353"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102934","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine chloride-loaded polymeric lipid hybrid nanoparticles ameliorate cognitive impairment by reducing phosphorylation of tau at threonine 231","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102934"}}